Sugi Predict

Sugi Predict / Compounds / SCHEMBL95723

SCHEMBL95723

SCHEMBL95723

O=Cc1c(F)cc(F)cc1F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ERN1 O75460 2/20 0.50
▸ PTP4A3 O75365 1/20 0.37
▸ CES2 O00748 3/20 0.37
▸ CES1 P23141 3/20 0.37
▸ ALDH1A1 P00352 3/20 0.33
▸ HTT P42858 1/20 0.33
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ LMNA P02545 1/20 0.32
▸ TGM2 P21980 1/20 0.32
▸ TDP1 Q9NUW8 2/20 0.31
▸ CA12 O43570 1/20 0.30
▸ CA1 P00915 1/20 0.30
▸ CA9 Q16790 1/20 0.30
▸ PIK3CD O00329 1/20 0.30
▸ ABL1 P00519 1/20 0.30
▸ EGFR P00533 1/20 0.30
▸ HCK P08631 1/20 0.30
▸ SRC P12931 1/20 0.30
▸ KDR P35968 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9712527 0.83 ERN1 (0.42) ERN1PTP4A3CES2CES1ALDH1A1
SCHEMBL29824002 0.83 ERN1 (0.42) ERN1PTP4A3CES2CES1ALDH1A1
SCHEMBL29921076 0.83 ERN1 (0.42) ERN1PTP4A3CES2CES1ALDH1A1
SCHEMBL6556132 0.83 ERN1 (0.42) ERN1PTP4A3CES2CES1ALDH1A1
SCHEMBL3967319 0.83 ERN1 (0.52) ERN1PTP4A3CES2CES1CA12
SCHEMBL29956613 0.83 ERN1 (0.42) ERN1PTP4A3CES2CES1ALDH1A1
SCHEMBL19126505 0.83 ERN1 (0.42) ERN1PTP4A3CES2CES1ALDH1A1
SCHEMBL1811153 0.80 ALDH1A1 (0.39) ERN1ALDH1A1
SCHEMBL28225743 0.79 HSD17B10 (0.59) ERN1ALDH1A1HTT
SCHEMBL9342725 0.79 KIF11 (0.41) ERN1PTP4A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 638 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118459422-A Thiazole thiazolinone compound containing multiple halogen atoms and preparation method thereof 南京工业大学 2024-08-09 — — CN claimed
CN-118459420-A Thiazolinone compound containing multiple halogen atoms and preparation method thereof 南京工业大学 2024-08-09 — — CN claimed
CN-115611717-B Preparation method of polyfluorobenzaldehyde 上海万溯药业有限公司 2024-06-28 — — CN claimed
CN-118085334-A High-tensile swelling-resistant polyvinyl alcohol-based hydrogel and preparation method and application thereof 国科广化(南雄)新材料研究院有限公司 2024-05-28 — — CN claimed
CN-117126076-A Preparation method of 2,4, 6-trifluorobenzyl cyanide 清源创新实验室 2023-11-28 — — CN claimed
CN-110963922-B Preparation method of 2,4, 6-trifluoro-benzylamine 成都博腾药业有限公司 2023-09-05 — — CN claimed
CN-116217897-A Polyelectrolyte material, preparation method thereof and cation selective separation membrane 中国科学技术大学 2023-06-06 — — CN claimed
CN-115611717-A Preparation method of polyfluorobenzaldehyde 上海万溯药业有限公司 2023-01-17 — — CN claimed
CN-115477635-A Preparation method of rasemiptan 山东新时代药业有限公司 2022-12-16 — — CN claimed
CN-107043322-B Preparation method of 2,4, 6-trifluorobenzaldehyde 绍兴上虞华伦化工有限公司 2020-08-25 — — CN claimed
US-20040132807-A1 Aurones as telomerase inhibitors PHARMACIA ITALIA SPA (IT) 2004-07-08 — — US claimed
US-20040087816-A1 Preparation of 1,3-di-halo-substituted benzene derivatives CLARIANT GMBH 2004-05-06 — — US claimed
EP-1413566-A1 Process for the preparation of 1,3-dihalo substituted benzene derivatives Clariant GmbH (DE) 2004-04-28 — — EP claimed
EP-1390336-A1 METHOD FOR PRODUCING AROMATIC ALDEHYDES AND KETONES BY THE CATALYTIC OXIDATION OF ALKYL-AROMATIC COMPOUNDS DSM Fine Chemicals Austria Nfg GmbH & Co KG (AT) 2004-02-25 — — EP claimed
EP-1381359-A1 AURONES AS TELOMERASE INHIBITORS Pharmacia Italia S.p.A. (IT) 2004-01-21 — — EP claimed
US-20030162963-A1 Novel expanded porphyrins and process for the synthesis thereof JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2003-08-28 — — US claimed
EP-1306380-A1 NOVEL EXPANDED PORPHYRINS AND PROCESS FOR THE SYNTHESIS THEREOF Japan Science and Technology Corporation (JP) 2003-05-02 — — EP claimed
WO-2002096849-A1 METHOD FOR PRODUCING AROMATIC ALDEHYDES AND KETONES BY THE CATALYTIC OXIDATION OF ALKYL-AROMATIC COMPOUNDS DSM FINE CHEMICALS AUSTRIA NFG GMBH & CO KG (AT) 2002-12-05 — — WO claimed
WO-2002083123-A1 AURONES AS TELOMERASE INHIBITORS PHARMACIA ITALIA SPA (IT) 2002-10-24 — — WO claimed
US-6150378-A 1-((1-HALO-SUBSTITUTEDBENZOYLAMINO)-2-PHENYLETHYL)-CARBONYL -CARBONYLAMINO),2-PHENYL OR PYRID-2-YLSULFAMIDO)ETHANE DERIVATIVES; MUSCULAR DYSTROPHY, NEURODEGENERATION, STROKE, ALZHEIMER'S, AMYOTROPHY, MOTOR NEURON DAMAGE, CNS INJURY CEPHALON, INC. (US) 2000-11-21 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040087816-A1 Preparation of 1,3-di-halo-substituted benzene derivatives HAO2, AOC2, AOC3 ERN1 2345/4885PTP4A3 4110/4885CES2 953/4885
US-20030162963-A1 Novel expanded porphyrins and process for the synthesis thereof AAAS, PAM, AHR ERN1 4868/4885PTP4A3 1269/4885CES2 4013/4885
US-20040132807-A1 Aurones as telomerase inhibitors TERT, TERF2, TERF2IP ERN1 572/4885PTP4A3 2969/4885CES2 4303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.